Human T-Cell Lymphotropic Virus Type 1 Tax Represses c-Myb-Dependent Transcription through Activation of the NF-κB Pathway and Modulation of Coactivator Usage

REFERENCES

• Akagi, T., H. Ono, N. Tsuchida, and K. Shimotohno. 1997. Aberrant expression and function of p53 in T-cells immortalized by HTLV-1 Tax-1. FEBS Lett. 406:263–266.
   PubMedGoogle Scholar
• Beg, A. A., W. C. Sha, R. T. Bronson, and D. Baltimore. 1995. Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. Genes Dev. 22:2736–2746.
   Google Scholar
• Beg, A. A., W. C. Sha, R. T. Bronson, S. Gosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376:167–170.
   PubMed Web of Science ®Google Scholar
• Bender, T. P., C. B. Thompson, and W. M. Kuehl. 1987. Differential expression of c-myb mRNA in murine B lymphomas by a block to transcription elongation. Science 237:1473–1476.
   PubMed Web of Science ®Google Scholar
• Bies, J., V. Nazarov, and L. Wolff. 1999. Identification of protein instability determinants in the carboxy-terminal region of c-Myb removed as a result of retroviral integration in murine monocytic leukemias. J. Virol. 73:2038–2044.
   PubMedGoogle Scholar
• Bressler, P., K. Brown, W. Timmer, V. Bours, U. Siebenlist, and A. S. Fauci. 1993. Mutational analysis of the p50 subunit of NF-kappa B and inhibition of NF-kappa B activity by trans-dominant p50 mutants. J. Virol. 67:288–293.
   PubMedGoogle Scholar
• Cereseto, A., P. R. Washington, E. Rivadeneira, and G. Franchini. 1999. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells. Oncogene 18:2441–2450.
   PubMed Web of Science ®Google Scholar
• Chrivia, J. C., R. P. Kwok, N. Lamb, M. Hagiwara, M. R. Montminy, and R. H. Goodman. 1993. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855–859.
   PubMed Web of Science ®Google Scholar
• Cogswell, J. P., P. C. Cogswell, W. M. Kuehl, A. M. Cuddihy, T. M. Bender, U. Engelke, K. B. Marcu, and J. P. Ting. 1993. Mechanism of c-myc regulation by c-Myb in different cell lineages. Mol. Cell. Biol. 13:2858–2869.
   PubMed Web of Science ®Google Scholar
• Dai, P., H. Akimaru, Y. Tanaka, D. X. Hou, T. Yasukawa, C. Kanei-Ishii, T. Takahashi, and S. Ishii. 1996. CBP as a transcriptional coactivator of c-Myb. Genes Dev. 10:528–540.
   PubMedGoogle Scholar
• Dash, A. B., F. C. Orrico, and S. A. Ness. 1996. The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb. Genes Dev. 10:1858–1869.
   PubMed Web of Science ®Google Scholar
• Eckner, R., M. E. Ewen, D. Newsome, M. Gerdes, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston. 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8:869–884.
   PubMed Web of Science ®Google Scholar
• Fu, S. L., and J. S. Lipsick. 1996. FAETL motif required for leukemic transformation by v-Myb. J. Virol 70:5600–5610.
   PubMed Web of Science ®Google Scholar
• Geleziunas, R., S. Ferrell, X. Lin, Y. Mu, E. T. Cunningham Jr., M. Grant, M. A. Connelly, J. E. Hambor, K. B. Marcu, and W. C. Greene. 1998. Human T-cell leukemia virus type 1 Tax induction of NF-κB involves activation of the IκB kinase α (IKKα) and IKKβ cellular kinases. Mol. Cell. Biol. 18:5157–5165.
   PubMed Web of Science ®Google Scholar
• Gessain, A., F. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. De The. 1985. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet ii:407–410.
   Google Scholar
• Gewirtz, A. M.. 1999. Myb targeted therapeutics for the treatment of human malignancies. Oncogene 18:3056–3062.
   PubMed Web of Science ®Google Scholar
• Gonda, T. J., and D. Metcalf. 1984. Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature 310:249–251.
   PubMed Web of Science ®Google Scholar
• Guerra, J., D. A. Withers, and L. M. Boxer. 1995. Myb binding sites mediate negative regulation of c-myb expression in T-cell lines. Blood 86:1873–1880.
   PubMedGoogle Scholar
• Harris, A. W., A. Strasser, M. L. Bath, A. G. Elefanty, and S. Cory. 1997. Lymphomas and plasmacytomas in transgenic mice involving bcl2, myc and v-abl. Curr. Top. Microbiol. Immunol. 224:221–230.
   PubMedGoogle Scholar
• Hedge, S. P., A. Kumar, C. Kurschner, and L. H. Shapiro. 1998. c-Maf interacts with c-Myb to regulate transcription of an early myeloid gene during differentiation. Mol. Cell. Biol. 18:2729–2737.
   PubMedGoogle Scholar
• Horvai, A. E., L. Xu, E. Korzus, G. Brard, D. Kalafus, T. M. Mullen, D. W. Rose, M. G. Rosenfeld, and C. K. Glass. 1997. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc. Natl. Acad. Sci. USA 94:1074–1079.
   PubMedGoogle Scholar
• Hottiger, M. O., and G. J. Nabel. 1998. Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein. J. Virol. 72:8252–8256.
   PubMed Web of Science ®Google Scholar
• Jeang, K. T., S. G. Widen, O. J. Semmes, and S. H. Wilson. 1990. HTLV-I trans-activator protein, Tax, is a trans-repressor of the human beta-polymerase gene. Science 247:1082–1084.
   PubMed Web of Science ®Google Scholar
• Jin, D. Y., F. Spencer, and K. T. Jeang. 1998. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 93:81–91.
   PubMed Web of Science ®Google Scholar
• Jin, D. Y., V. Giordano, K. V. Kibler, H. Nakano, and K. T. Jeang. 1999. Role of adapter function in oncoprotein-mediated activation of NF-kappaB. Human T-cell leukemia virus type I Tax interacts directly with IkappaB kinase gamma. J. Biol. Chem. 274:17402–17405.
   PubMed Web of Science ®Google Scholar
• Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S. C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403–414.
   PubMed Web of Science ®Google Scholar
• Kaspar, P., M. Dvorakova, J. Kralova, P. Pajer, Z. Kozmik, and M. Dvorak. 1999. Myb-interacting protein, ATBF1, represses transcriptional activity of Myb oncoprotein. J. Biol. Chem. 274:14422–14428.
   PubMedGoogle Scholar
• Lemasson, I., V. Robert-Hebmann, S. Hamaia, D. M. Duc, L. Gazzolo, and C. Devaux. 1997. Trans-repression of lck gene expression by human T-cell leukemia virus type 1-encoded p40tax. J. Virol. 71:1975–1983.
   PubMed Web of Science ®Google Scholar
• Lenzmeier, B. A., E. E. Baird, P. B. Dervan, and J. K. Nyborg. 1999. The Tax protein-DNA interaction is essential for HTLV-I transactivation in vitro. J. Mol. Biol. 291:731–744.
   PubMedGoogle Scholar
• Leverson, J. D., P. J. Koskinen, F. C. Orrico, E. M. Rainio, K. J. Jalkanen, A. B. Dash, R. N. Eisenman, and S. A. Ness. 1998. Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Mol. Cell 2:417–425.
   PubMed Web of Science ®Google Scholar
• Leverson, J. D., and S. A. Ness. 1998. Point mutations in v-Myb disrupt a cyclophilin-catalyzed negative regulatory mechanism. Mol. Cell 1:203–211.
   PubMedGoogle Scholar
• Li, X. H., and R. B. Gaynor. 1999. Regulation of NF-kB by the HTLV-1 Tax protein. Gene Exp. 7:233–245.
   PubMedGoogle Scholar
• Lipsick, J. S., and D. M. Wang. 1999. Transformation by v-Myb. Oncogene 18:3047–3055.
   PubMed Web of Science ®Google Scholar
• Mink, S., U. Kerber, and K. H. Klempnauer. 1996. Interaction of C/EBPβ and v-Myb is required for synergistic activation of the mim-1 gene. Mol. Cell. Biol. 16:1316–1325.
   PubMedGoogle Scholar
• Ness, S. A.. 1999. Myb binding proteins: regulators and cohorts in transformation. Oncogene 18:3039–3046.
   PubMedGoogle Scholar
• Ness, S. A., A. Marknell, and T. Graf. 1989. The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell 59:1115–1125.
   PubMed Web of Science ®Google Scholar
• Neuveut, C., K. G. Low, F. Maldarelli, I. Schmitt, F. Majone, R. Grassmann, and K. T. Jeang. 1998. Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclin D-cdk and p110Rb. Mol. Cell. Biol. 18:3620–3632.
   PubMed Web of Science ®Google Scholar
• Nicot, C., and R. Harrod. 2000. Distinct p300-responsive mechanisms promote caspase-dependent apoptosis by human T-cell lymphotropic virus type 1 Tax protein. Mol. Cell. Biol. 20:8580–8589.
   PubMedGoogle Scholar
• Nicot, C., R. Mahieux, R. Opavsky, A. Cereseto, L. Wolff, J. N. Brady, and G. Franchini. 2000. HTLV-I Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300. Oncogene 19:2155–2164.
   PubMedGoogle Scholar
• Nicot, C., R. Opavsky, R. Mahieux, J. M. Johnson, J. N. Brady, L. Wolff, and G. Franchini. 2000. Tax oncoprotein trans-represses endogenous B-myb promoter activity in human T cells. AIDS Res. Hum. Retrovir. 16:1629–1632.
   PubMedGoogle Scholar
• Nicot, C., R. Mahieux, S. Takemoto, and G. Franchini. 2000. Bcl-X(L) is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples. Blood 96:275–281.
   PubMedGoogle Scholar
• Oelgeschlager, M., R. Janknecht, J. Krieg, S. Schreek, and B. Luscher. 1996. Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M. EMBO J. 15:2771–2780.
   PubMedGoogle Scholar
• Oelgeschlager, M., J. Krieg, J. M. Luscher-Firzlaff, and B. Luscher. 1995. Casein kinase II phosphorylation site mutations in c-Myb affect DNA binding and transcriptional cooperativity with NF-M. Mol. Cell. Biol. 15:5966–5974.
   PubMedGoogle Scholar
• Oelgeschlager, M., I. Nuchprayoon, B. Luscher, and A. D. Friedman. 1996. C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol. Cell. Biol. 16:4717–4725.
   PubMed Web of Science ®Google Scholar
• Osame, M., K. Usuku, S. Izumo, N. Ljichi, H. Amitani, A. Igata, M. Matsumoto, and M. Tara. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet i:1031–1032.
   Google Scholar
• Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415–7419.
   PubMed Web of Science ®Google Scholar
• Postigo, A. A., A. M. Sheppard, M. L. Mucenski, and D. C. Dean. 1997. c-Myb and Ets proteins synergize to overcome transcriptional repression by ZEB. EMBO J. 16:3924–3934.
   PubMedGoogle Scholar
• Reddy, C. D., and E. P. Reddy. 1989. Differential binding of nuclear factors to the intron 1 sequences containing the transcriptional pause site correlates with c-myb expression. Proc. Natl. Acad. Sci. USA 86:7326–7330.
   PubMed Web of Science ®Google Scholar
• Reed, J. C., M. Cuddy, S. Haldar, C. Croce, P. Nowell, D. Makover, and K. Bradley. 1990. BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense. Proc. Natl. Acad. Sci. USA 87:3660–3664.
   PubMed Web of Science ®Google Scholar
• Schmidt, M., V. Nazarov, L. Stevens, R. Watson, and L. Wolff. 2000. Regulation of the resident chromosomal copy of c-myc by c-Myb is involved in myeloid leukemogenesis. Mol. Cell. Biol. 20:1970–1981.
   PubMed Web of Science ®Google Scholar
• Sha, W. C., H. C. Liou, E. I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80:321–330.
   PubMed Web of Science ®Google Scholar
• Smith, M. R., and W. C. Greene. 1990. Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev. 4:1875–1885.
   PubMed Web of Science ®Google Scholar
• Suhasini, M., and R. B. Pilz. 1999. Transcriptional elongation of c-myb is regulated by NF-kappaB (p50/RelB). Oncogene 18:7360–7369.
   PubMedGoogle Scholar
• Suhasini, M., C. D. Reddy, E. P. Reddy, J. A. DiDonato, and R. B. Pilz. 1997. cAMP-induced NF-kappaB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation. Oncogene 15:1859–1870.
   PubMedGoogle Scholar
• Sun, S. C., P. A. Ganchi, D. W. Ballard, and W. C. Greene. 1993. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 259:1912–1915.
   PubMed Web of Science ®Google Scholar
• Suzuki, T., S. Kitao, H. Matsushime, and M. Yoshida. 1996. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J. 15:1607–1614.
   PubMed Web of Science ®Google Scholar
• Tanaka, Y., I. Naruse, T. Maekawa, H. Masuya, T. Shiroishi, and S. Ishii. 1997. Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi syndrome. Proc. Natl. Acad. Sci. USA 94:10215–10220.
   PubMed Web of Science ®Google Scholar
• Tavner, F. J., R. Simpson, S. Tashiro, D. Favier, N. A. Jenkins, D. J. Gilbert, N. G. Copeland, E. M. Macmillan, J. Lutwyche, R. A. Keough, S. Ishii, and T. J. Gonda. 1998. Molecular cloning reveals that the p160 Myb-binding protein is a novel, predominantly nucleolar protein which may play a role in transactivation by Myb. Mol. Cell. Biol. 18:989–1002.
   PubMed Web of Science ®Google Scholar
• Taylor, D., P. Badiani, and K. Weston. 1996. A dominant interfering Myb mutant causes apoptosis in T cells. Genes Dev. 10:2732–2744.
   PubMed Web of Science ®Google Scholar
• Tong, X., R. Drapkin, R. Yalamanchili, G. Mosialos, and E. Kieff. 1995. The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE. Mol. Cell. Biol. 15:4735–4744.
   PubMed Web of Science ®Google Scholar
• Verbeek, W., A. F. Gombart, A. M. Chumakov, C. Muller, A. D. Friedman, and H. P. Koeffler. 1999. C/EBPε directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters. Blood 93:3327–3337.
   PubMed Web of Science ®Google Scholar
• Wang, D., and A. S. Baldwin Jr.. 1998. Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529. J. Biol. Chem. 273:29411–29416.
   PubMedGoogle Scholar
• Wolff, L., M. Schmidt, R. Koller, P. Haviernick, R. Watson, J. Bies, and K. Maciag. 2001. Three genes with different functions in transformation are regulated by c-Myb in myeloid cells. Blood Cells Mol. Dis. 27:422–428.
   PubMedGoogle Scholar
• Xiao, G., E. W. Harhaj, and S. C. Sun. 2000. Domain-specific interaction with IkappaB kinase (IKK) regulatory subunit IKK gamma is an essential step in Tax-mediated activation of IKK. J. Biol. Chem. 275:34060–34067.
   PubMedGoogle Scholar
• Yamaoka, S., G. Courtois, C. Bessia, S. T. Whiteside, R. Weil, F. Agou, H. E. Kirk, R. J. Kay, and A. Israel. 1998. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 93:1231–1240.
   PubMed Web of Science ®Google Scholar
• Yao, T. P., S. P. Oh, M. Fuchs, N. D. Zhou, L. E. Ch'ng, D. Newsome, R. T. Bronson, E. Li, D. M. Livingston, and R. Eckner. 1998. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93:361–372.
   PubMed Web of Science ®Google Scholar
• Yin, M. J., L. B. Christerson, Y. Yamamoto, Y. T. Kwak, S. Xu, F. Mercurio, M. Barbosa, M. H. Cobb, and R. B. Gaynor. 1998. HTLV-I Tax protein binds to MEKK1 to stimulate IkappaB kinase activity and NF-kappaB activation. Cell 93:875–884.
   PubMed Web of Science ®Google Scholar
• Zhong, H., R. E. Voll, and S. Ghosh. 1998. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1:661–671.
   PubMed Web of Science ®Google Scholar